Soaring Eagle Acquisition Corp

Soaring Eagle Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on October 22, 2020 and is headquartered in Los Angeles, CA. Redemption Price: 10.04. Warrant Coverage: 1/5.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

The Special Purpose Acquisition Company (SPAC) begins trading publicly. During this phase the SPAC looks for a target company to merge with or acquire.

SEARCHING PHASE

The SPAC announces which company it will be acquiring (and taking public).

PREVIOUS PHASE

Investors and shareholders will meet to approve the acquisition.

CURRENT PHASE

Ginkgo Bioworks Holdings

Radnor, Pennsylvania--(Newsfile Corp. - November 27, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Ginkgo Bioworks Holdings, Inc. ("Ginkgo") (NYSE: DNA) f/k/a Soaring Eagle Acquisition Corp. (NASDAQ: SRNG). The action charges Ginkgo with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects. As a result of Ginkgo's materially...

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against of Ginkgo Bioworks Holdings, Inc. Investors - DNA

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. (NYSE: DNA; NASDAQ: SRNG) between May 11, 2021 and October 5, 2021, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 18, 2022. SO WHAT: I

ROSEN, A LEADING LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – DNA, SRNG

RADNOR, Pa., Nov. 23, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Ginkgo Bioworks Holdings, Inc. ("Ginkgo") (NYSE: DNA) f/k/a Soaring Eagle Acquisition Corp. (NASDAQ: SRNG).

DNA CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Shareholders of Securities Fraud Class Action Lawsuit

New York, New York--(Newsfile Corp. - November 22, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. (NYSE: DNA) (NASDAQ: SRNG) between May 11, 2021 and October 5, 2021, both dates inclusive (the "Class Period"). A class action has already been filed. If you wish to serve...

ROSEN, A TOP RANKED LAW FIRM, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - DNA, SRNG

Los Angeles, California--(Newsfile Corp. - November 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. ("Ginkgo" or "the Company") (NYSE: DNA) (NASDAQ: SRNG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May...

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Radnor, Pennsylvania--(Newsfile Corp. - October 12, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo") f/k/a Soaring Eagle Acquisition Corp. (NASDAQ: SRNG) ("Soaring Eagle").Ginkgo develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals...

Ginkgo Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. Investors

RADNOR, Pa., Oct. 8, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP is currently investigating potential violations of the federal securities laws on behalf of shareholders of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo") f/k/a Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle").

Ginkgo Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) Investors

Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. Gingko's market debut is one of the largest in biotech history.

Gingko Bioworks, valued at $15B, begins trading today: Here's how their business works

BOSTON, Sept. 17, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a special purpose acquisition company, today announced the closing of their previously announced business combination.

Ginkgo Bioworks to Begin Trading Today as NYSE: DNA with Over $1.6 Billion in Proceeds

Soaring Eagle Acquisition is about to complete its merger with Ginkgo Bioworks, and SRNG stock is reacting well. Here's why.

Dear SRNG Stock Fans, Mark Your Calendars for Ginkgo Bioworks' Debut on Sept. 17

Oatly

Wisdomtree BioRevolution Fund

Zymergen

BioRevolution is a new and rapidly growing set of tools that are increasingly allowing us to read, write and hack that code of life with greater speed and precision and a rapidly decreasing cost. Health care is the most mature sector of those we are investing in, and even in health care, it's still early.

All Aboard For The BioRevolution

BOSTON, Sept. 9, 2021 /PRNewswire/ -- Ginkgo Bioworks  ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced the launch of Verb Biotics ("Verb"), a probiotics innovation company that will identify and design new strains of probiotic bacteria with advanced properties for human nutrition, health, and wellness.

Ginkgo Bioworks' Ferment Consortium Launches Verb Biotics, a Probiotics Innovation Company to Address Market Demands for Effective Probiotics

BOSTON, Sept. 7, 2021 /PRNewswire/ -- Tantu, a company engineering living biotherapeutic products to treat gastrointestinal diseases, and Ginkgo Bioworks ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the research and development of Tantu's therapeutic genes.

Tantu and Ginkgo Bioworks Announce Partnership to Engineer a Living Biotherapeutic for Gastrointestinal Healing

BOSTON, Sept. 3, 2021 /PRNewswire/ -- Ginkgo Bioworks Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming and recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), today announced that management is scheduled to participate in the following upcoming conferences: Morgan Stanley Healthcare Conference  on Thursday September 9, 2021, at 8:45 a.m.

Ginkgo Bioworks Announces Participation In Upcoming Virtual Conferences

Cambium Biomaterials ("Cambium"), the company creating high-performance biomaterials, today announced a partnership with Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), serves customers across industries seeking to develop new and better products using biology. The partnership will leverage Ginkgo's Codebase and high-throughput facility to accelerate Cambium's discovery, development, manufacturing and commercialization of biomaterials that deliver superior performance and sustainability across a range of industries.

Cambium Biomaterials Announces Partnership with Ginkgo Bioworks to Accelerate Industrial Adoption of High-Performance Biomaterials

BOSTON, Aug. 30, 2021 /PRNewswire/ --  Ginkgo Bioworks , Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced the signing of a multi-program collaboration with Givaudan , the world's leading Taste & Wellbeing and Fragrance & Beauty company. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), serves customers across industries seeking to develop new and better products.

Ginkgo Bioworks and Givaudan Enter Multi-Program Collaboration to Produce a Series of Ingredients

BOSTON, Aug. 19, 2021 /PRNewswire/ --   Ginkgo Bioworks , Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced a new cell program in partnership with Huue , a biotech startup that's pioneering sustainable bio-based dyes for the fashion industry and beyond. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), serves customers across industries seeking to develop new and better products using biology.

Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes

BOSTON, Aug. 18, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo") (the "Company"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), today announced a revenue and business update for the first half of 2021. "Ginkgo's business momentum has accelerated in 2021.

Ginkgo Bioworks Provides First Half 2021 Update

The synthetic biology company is going public through one of the largest SPAC mergers in history. Is the stock worth paying up for?

Is Ginkgo Bioworks Worth the Hype?

Adaptive Biotechnologies

UiPath

ARK Invest made multiple purchases of these stocks last week.

3 Life Science Stocks Cathy Wood's Buying Hand Over Fist Right Now

NEW YORK--(BUSINESS WIRE)-- #ginkgobioworks--Soaring Eagle Acquisition Corp., a Cayman Islands exempted company limited by shares (the “Company” or “Soaring Eagle”) (Nasdaq: SRNG.U, SRNG, SRNG WS), announced today that it has scheduled the extraordinary general meeting of the Company's shareholders (the "Special Meeting") in connection with its business combination (the "Business Combination") with Ginkgo Bioworks, Inc. to be held on September 14, 2021. Notice of the Special Meeting and a proxy statement/prospec

Soaring Eagle Announces Extraordinary General Meeting Date for Proposed Business Combination with Ginkgo

MENLO PARK, Calif. and BOSTON, Aug. 12, 2021 /PRNewswire/ -- Antheia , a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks , which is building the leading horizontal platform for cell programming, today announced a partnership to accelerate the development and production of essential medicines.

Antheia and Ginkgo Bioworks Announce Partnership to Accelerate Production of Essential Medicines using Synthetic Biology

BOSTON and NEW YORK, Aug. 11, 2021 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle") announced today that the Securities and Exchange Commission (the "SEC") has declared effective the Registration Statement on Form S-4 filed by Soaring Eagle with the SEC relating to the previously announced business combination between Ginkgo and Soaring Eagle (the "Business Combination"). "This is an important milestone in our path towards becoming a publicly traded company," commented Jason Kelly, the co-founder and Chief Executive Officer of Ginkgo.

Ginkgo Bioworks and Soaring Eagle Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement

Ark Invest first began purchasing shares of the Ginkgo Bioworks SPAC on August 3 and now owns 14.5 million shares worth about $150 million.

Cathie Wood's Ark Invest just doubled a multi-million-share position in a SPAC merging with Ginkgo Bioworks

ARK Genomic Revolution Multi-Sector ETF

ARK Innovation ETF

One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought nearly 2 million shares of Soaring Eagle Acquisition Corp.

News for Soaring Eagle Acquisition Corp Stock (SRNG)